Loading cart

National Prostate Cancer Dataset Specification Pilot Project: Seeking Expressions of Interest

Release Date: 

09/07/2012

News Type: 

  • Announcement

Cancer Australia and Andrology Australia are developing a Prostate Cancer Dataset Specification to assist clinical monitoring and reporting of the treatment and care received by men affected by prostate cancer. It is anticipated that once complete, this dataset specification will become a nationally recommended standard for clinical prostate cancer data collection.

Piloting of the dataset is critical to ensure its adequacy for use in clinical settings. We are currently seeking up to three sites in different states and territories in Australia that are involved in the treatment of newly diagnosed prostate cancer patients, to take part in piloting this dataset specification. The piloting of this dataset will involve collecting patient data for a 3-4 month period between September 2012 and April 2013. Funding for involvement in the project will be provided.

To take part in the pilot, please download and complete the application form below. Applications should be returned to Simeon.Jones@canceraustralia.gov.au no later than 5:00pm Eastern Daylight Time on 10 August 2012.

Update:

Cancer Australia advises that the addendum outlining clarification questions and our responses regarding the recently advertised Expressions of Interest (EoI) call for piloting of the Prostate Cancer DSS has now been released (see below). Cancer Australia will continue to update this addendum as required and any further enquiries can be accepted up to 5.00pm (EST) on 5 August 2012. Applicants are advised to check the Cancer Australia website prior to submission of applications on/before this date.

Note:

Due to technical issues experienced with the pdf application form, we have provided a word version of the application form for submission to Cancer Australia.

For any further information please contact Christine Biondi via Christine.Biondi@canceraustralia.gov.au or by calling 02 6217 9811.